Jones Financial Companies Lllp Buys 115 Shares of DaVita Inc. (NYSE:DVA)

Jones Financial Companies Lllp lifted its stake in DaVita Inc. (NYSE:DVA) by 28.6% during the fourth quarter, Holdings Channel reports. The fund owned 517 shares of the company’s stock after acquiring an additional 115 shares during the quarter. Jones Financial Companies Lllp’s holdings in DaVita were worth $77,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in DVA. MML Investors Services LLC raised its position in shares of DaVita by 1.3% in the third quarter. MML Investors Services LLC now owns 5,300 shares of the company’s stock valued at $869,000 after purchasing an additional 68 shares during the period. Exchange Traded Concepts LLC grew its stake in DaVita by 8.3% in the 4th quarter. Exchange Traded Concepts LLC now owns 891 shares of the company’s stock valued at $133,000 after buying an additional 68 shares during the last quarter. Impact Partnership Wealth LLC raised its holdings in DaVita by 3.7% in the 4th quarter. Impact Partnership Wealth LLC now owns 1,941 shares of the company’s stock worth $290,000 after acquiring an additional 70 shares during the period. Contravisory Investment Management Inc. boosted its holdings in DaVita by 1.2% during the fourth quarter. Contravisory Investment Management Inc. now owns 6,082 shares of the company’s stock valued at $910,000 after acquiring an additional 73 shares during the period. Finally, Nilsine Partners LLC grew its position in shares of DaVita by 0.8% in the fourth quarter. Nilsine Partners LLC now owns 11,160 shares of the company’s stock valued at $1,669,000 after purchasing an additional 92 shares during the last quarter. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on DVA. Barclays boosted their price objective on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 18th. Cowen reissued a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a research report on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, DaVita currently has a consensus rating of “Hold” and a consensus price target of $166.33.

DaVita Price Performance

Shares of DVA stock opened at $143.56 on Monday. DaVita Inc. has a 12 month low of $125.64 and a 12 month high of $179.60. The company has a market capitalization of $11.48 billion, a P/E ratio of 13.37, a P/E/G ratio of 1.07 and a beta of 0.99. The stock has a 50 day moving average of $158.92 and a two-hundred day moving average of $157.65. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA) last issued its earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, equities analysts expect that DaVita Inc. will post 10.76 EPS for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.